What is HC Wainwright’s Forecast for REGENXBIO Q2 Earnings?
REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Stock analysts at HC Wainwright upped their Q2 2025 earnings estimates for shares of REGENXBIO in a note issued to investors on Tuesday, May 13th. HC Wainwright analyst Y. Chen now anticipates that the biotechnology company will post earnings of ($1.17) per share for the quarter, up from […]
